A detailed history of Stablepoint Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Stablepoint Partners, LLC holds 20,474 shares of AMGN stock, worth $6.64 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
20,474
Previous 11,387 79.8%
Holding current value
$6.64 Million
Previous $3.24 Billion 110.28%
% of portfolio
1.32%
Previous 0.66%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$262.75 - $319.31 $2.39 Million - $2.9 Million
9,087 Added 79.8%
20,474 $6.81 Billion
Q1 2024

Apr 23, 2024

BUY
$268.87 - $324.56 $526,716 - $635,813
1,959 Added 20.78%
11,387 $3.24 Billion
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $2.41 Million - $2.72 Million
9,428 New
9,428 $2.72 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $174B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Stablepoint Partners, LLC Portfolio

Follow Stablepoint Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stablepoint Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stablepoint Partners, LLC with notifications on news.